| 000 | 01754 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512120136.0 | ||
| 264 | 0 | _c19730130 | |
| 008 | 197301s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLodish, H F | |
| 245 | 0 | 0 |
_aRegulation of hemoglobin synthesis. Preferential inhibition of and globin synthesis. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cDec 1972 |
||
| 300 |
_a7822-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenine Nucleotides _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCarbon Isotopes |
| 650 | 0 | 4 | _aCell-Free System |
| 650 | 0 | 4 |
_aCytosine Nucleotides _xpharmacology |
| 650 | 0 | 4 |
_aDeoxyribonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aGlobins _xbiosynthesis |
| 650 | 0 | 4 |
_aHemoglobins _xbiosynthesis |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aInosine Nucleotides _xpharmacology |
| 650 | 0 | 4 |
_aMagnesium _xpharmacology |
| 650 | 0 | 4 | _aOsmolar Concentration |
| 650 | 0 | 4 |
_aPeptide Chain Elongation, Translational _xdrug effects |
| 650 | 0 | 4 |
_aPeptide Chain Initiation, Translational _xdrug effects |
| 650 | 0 | 4 |
_aPeptide Chain Termination, Translational _xdrug effects |
| 650 | 0 | 4 |
_aPoly U _xpharmacology |
| 650 | 0 | 4 |
_aPolynucleotides _xpharmacology |
| 650 | 0 | 4 |
_aPolyribosomes _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Viral _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReticulocytes _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aThalassemia _xdrug therapy |
| 650 | 0 | 4 |
_aThymine Nucleotides _xpharmacology |
| 700 | 1 | _aNathan, D G | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 247 _gno. 23 _gp. 7822-9 |
|
| 999 |
_c4640143 _d4640143 |
||